Table 3.
Frequency (%) and duration (mean±SE) (days) of most commonly coadministered QT-prolonging drugs1
![]() |
Percentage represents number of patients receiving specified drug combination relative to all patients receiving coadministered QT-prolonging drugs
Numbers in parentheses refer to risk of drug associated torsade de pointes as detailed in Table 1.